OH ANDREW M. 4
4 · Rubius Therapeutics, Inc. · Filed May 19, 2020
Insider Transaction Report
Form 4
OH ANDREW M.
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-05-15−5,000→ 755,500 totalExercise: $4.74Exp: 2028-02-14→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2020-05-15$4.74/sh+5,000$23,700→ 5,000 total
Footnotes (1)
- [F1]25% of this option shall vest on December 13, 2018, then in 12 equal quarterly installments thereafter.